Today: 17 April 2026
Browse Category

Stock Market 7 December 2025 - 8 December 2025

Rigetti Computing (RGTI) Stock: What to Know Before the Market Opens on December 8, 2025

Rigetti Computing (RGTI) Stock: What to Know Before the Market Opens on December 8, 2025

Rigetti Computing closed Friday at $28.11, down 6.5%, after a sharp reversal from Thursday’s rally. Shares have surged about 2,750% since January 2024 but remain down 57% from October highs. Market cap stands near $9.3 billion, with the stock trading at over 1,000 times sales. New analysis published December 7 highlights debate over valuation and future prospects.
Applied Materials (AMAT) Stock: 8 Things to Know Before the Market Opens on December 8, 2025

Applied Materials (AMAT) Stock: 8 Things to Know Before the Market Opens on December 8, 2025

Applied Materials closed Friday at $268.00, just below its record high, after a two-week gain of over 21%. New research out over the weekend warns the stock may be more than 70% above fair value, citing a sharp disconnect between price and earnings growth. SEC filings show mixed institutional moves, with some funds increasing stakes and others trimming positions.
8 December 2025
Reddit (RDDT) Stock: What to Know Before the Market Opens on December 8, 2025

Reddit (RDDT) Stock: What to Know Before the Market Opens on December 8, 2025

Reddit shares closed at $234.11 on Friday, up 5.1%, with a market cap near $44.4 billion. Institutional investors, including Northwestern Mutual and Amundi, sharply increased their holdings, while insiders sold about $83 million in stock this quarter. The company reported trailing 12-month revenue of $1.9 billion and a forward P/E near 70. Volatility remains high ahead of Monday’s session.
8 December 2025
Oklo (OKLO) Stock on December 8, 2025: What Investors Need to Know Before the Market Opens

Oklo (OKLO) Stock on December 8, 2025: What Investors Need to Know Before the Market Opens

Oklo Inc. closed Friday at $104.67, down 6.3% after a sharp rally earlier in the week, but remains up nearly 400–500% for 2025. The company launched a $1.5 billion at-the-market equity program, fueling volatility and dilution concerns. Oklo is pre-revenue, reported a Q3 loss of $36 million, and holds about $1.18 billion in cash. Analyst price targets range widely, and short interest stands at 12–15% of float.
8 December 2025
Johnson & Johnson (JNJ) Stock Near Record Highs: What to Know Before the Market Opens on December 8, 2025

Johnson & Johnson (JNJ) Stock Near Record Highs: What to Know Before the Market Opens on December 8, 2025

Johnson & Johnson closed Friday at just over $201, near its 52-week high of $207.81, with a market cap around $486 billion. The company reported positive CAR-T therapy data at ASH 2025 and gained access to China’s new drug reimbursement catalog. The board declared a Q4 dividend of $1.30 per share. About 67,670 federal talc lawsuits remain unresolved after a judge rejected J&J’s latest $10 billion settlement offer.
8 December 2025
Intuit (INTU) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Intuit (INTU) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Intuit shares closed Friday at $673.63, up 1.6%, with a market cap near $187.5 billion and a trailing P/E of 45–46. Fiscal Q1 2026 revenue rose 18% to $3.89 billion, beating forecasts. CalPERS increased its stake by 8%, while founder Scott Cook’s family trust sold about $99.5 million in stock but retains nearly 6 million shares. Intuit’s AI deals and product launches remain in focus.
8 December 2025
BitMine Immersion (BMNR) Stock: $199M ETH Buy, Record Treasury and What to Know Before the December 8, 2025 Open

BitMine Immersion (BMNR) Stock: $199M ETH Buy, Record Treasury and What to Know Before the December 8, 2025 Open

BitMine Immersion Technologies closed Friday at $34.06, down 6.2%, nearly 79% below its July high. The company bought $199 million in Ethereum this week, raising its crypto holdings to over 3% of total ETH supply. BitMine declared a $0.01 annual dividend and reported fiscal 2025 GAAP EPS of $13.39. One analyst rates the stock a “Strong Buy” with a $47 target, while others warn of mark-to-market risk.
Bloom Energy (BE) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Bloom Energy (BE) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Bloom Energy closed Friday at $119.18, near record highs, with a $28 billion market cap and a P/E above 600. Bosun Asset Management cut its stake by 71%, while Norges Bank disclosed a new $57.8 million position. Institutional investors now hold about 77% of the float. The stock has traded between $15 and $148 over the past year, with volatility near 120%.
Citigroup Stock (C) Before the Bell on December 8, 2025: Price, News, Forecasts and What Investors Need to Know

Citigroup Stock (C) Before the Bell on December 8, 2025: Price, News, Forecasts and What Investors Need to Know

Citigroup closed Friday, December 5, 2025, at $108.9, near its 52-week high and up 1% on the day. The stock has gained about 54% over the past year, with a market cap near $195 billion. New 13F filings show Callodine Capital and CalPERS increased their stakes, while Brown Advisory and Donald Smith & Co. trimmed positions. Institutional holders now account for roughly 72% of shares.
8 December 2025
Dollar General (DG) Stock: What to Know Before the Market Opens on December 8, 2025

Dollar General (DG) Stock: What to Know Before the Market Opens on December 8, 2025

Dollar General shares closed at $132.37 Friday after a 20% two-day rally driven by a Q3 earnings beat and raised full-year guidance. Net sales rose 4.6% to $10.6 billion, with EPS at $1.28 versus $0.95 expected. The stock trades near its 52-week high, nearly double its low, as analysts cite margin recovery but flag valuation concerns. Regulatory scrutiny over pricing accuracy remains a risk.
8 December 2025
Merck Stock (MRK) Before the Bell on December 8, 2025: Keytruda Setback, $8B Bond Deal and What Investors Should Watch

Merck Stock (MRK) Before the Bell on December 8, 2025: Keytruda Setback, $8B Bond Deal and What Investors Should Watch

Merck shares closed at $99.72 on Friday, down 1.16%, with volume above average. The stock sits about 6% below its November 52-week high and trades at roughly 13 times trailing earnings, with a dividend yield of 3.3–3.5%. A German court blocked Merck’s launch of subcutaneous Keytruda, citing patent infringement claims by Halozyme.
CoreWeave Stock (CRWV) Before the Bell on December 8, 2025: Profits, AI Deals and Big Risks

CoreWeave Stock (CRWV) Before the Bell on December 8, 2025: Profits, AI Deals and Big Risks

CoreWeave (NASDAQ: CRWV) closed Friday at $88.30, up 3% on the day and 20.8% for the week, after rebounding from a sharp November sell-off. Q3 revenue reached $1.36 billion, but the company posted a GAAP net loss of $110.1 million. Management cut 2025 revenue guidance and signaled $12–$14 billion in capital spending next year. Analysts remain divided, with targets ranging from $130 to $146.
Bank of America (BAC) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Bank of America (BAC) Stock: 10 Things to Know Before the Market Opens on December 8, 2025

Bank of America shares closed at $53.95 on Friday, near a record high, with a market cap of about $394 billion. CalPERS raised its stake by 6.1% in Q2, while Gamco and Guggenheim trimmed holdings. The stock was named a value pick by MarketBeat and is drawing strong institutional interest. BAC’s 2025 total return is estimated in the low-to-mid-20% range, ahead of many peers.
7 December 2025
Procter & Gamble (PG) Stock: 8 Things to Know Before the Market Opens on December 8, 2025

Procter & Gamble (PG) Stock: 8 Things to Know Before the Market Opens on December 8, 2025

Procter & Gamble shares closed at $143.45 on Friday, down 1.3%, near a two-year low after CFO Andre Schulten warned of sharply lower US sales and “nervous and cautious” consumers. The stock has fallen about 14.5% in 2025 and underperformed both the S&P 500 and Consumer Staples sector. Trading opens Monday with sentiment fragile and PG hovering just above its 52-week low of $142.51.
7 December 2025

Stock Market Today

  • India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks
    April 17, 2026, 4:51 AM EDT. Foreign institutional investors (FIIs) are growing cautious on India as new foreign exchange (FX) restrictions by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive. Concurrently, concerns over economic fallout from the Iran war and rising oil prices-India imports 90% of its oil-have pressured equities. Since the conflict began, foreign investors have offloaded $2.26 billion in government debt and $38 billion in shares, with record $12.7 billion equity outflows in March alone. Market strategists expect subdued sentiment and possibly higher bond yields before inflows return.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:51 AM EDT India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks April 17, 2026, 4:51 AM EDT. **Foreign institutional investors (FIIs)** are growing cautious on India as new **foreign exchange (FX) restrictions** by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive.
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop